Nordic Regulatory Affairs for pharma and biotech

Nordic Regulatory Affairs experts

Arex acts as your Nordic regulatory function for Sweden, Norway, Denmark, Finland and Iceland. We manage national applications, mutual recognition and decentralised procedures, post-approval changes and all communication with the Nordic authorities. We also offer strategic and hands-on support to affiliates in need of specialist competences.

Why the Nordics need local regulatory expertise

Each Nordic country has its own authority, language and product information requirements. Sweden, Norway, Denmark, Finland and Iceland all take part in the European procedures. Norway and Iceland do so as EEA members. Each market still applies national rules on labelling, language, product information databases and pricing and reimbursement.

Nordic regulatory affairs experts

Our local Nordic specialists help you succed with:

Lifecycle management
– proactive management of variations and renewals.

Regulatory project management – efficient management of timelines, stakeholders and submissions.

Database management – provided by specialists with deep understanding of the local requirements, ensuring correct management of FASS, LiiV, Felleskatalogen, Pharmaca Fennica and DKMAnet.

Local product information – experienced specialists to project manage production and review of labelling, package leaflets, and common artworks for all the Nordic markets.

Nordic compliance services

Insights from our Nordic experts

In a recent interview with Swedish healthcare publication Dagens Medicin, Nelly Fransén, Expert Regulatory Affairs and specialist in pharmaceutical formulation, discussed the practical and regulatory considerations involved in producing pharmacy-compounded alternatives to transdermal oestrogen medicines in Sweden. In this article, she shares further insights into the complexity of solving medicine
NLSDays 2026 brought the Nordic life science community together in Stockholm for two days of conversations, knowledge sharing and new connections. Arex Advisor CEO Linda Thunell shares some of her reflections through a regulatory affairs lens.
Fass (FASS) has, since 1966, been the central source of quality-assured pharmaceutical information in Sweden. 25 years ago, Fass went online for the first time. On November 8, the new Fass was launched, marking the most significant update and modernisation since its inception.
Your contact person

Lovisa Rosenquist

Founding Partner, COO

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.